Correlagen Diagnostics announced this week it is offering the HCM Sequencing Test for hypertrophic cardiomyopathy.
A genetic test for HCM, an inherited disease, can confirm whether a patient with unclear symptoms has the disease. Correlagen’s HCM Sequencing Test requires a cheek swab or a small blood sample from the patient. The company said physicians would send samples to Correlagen for analysis. However, the company did not specify which gene mutations it would test for.
“Correlagen’s highly automated testing processes allow for fast, accurate detection of disease-causing mutations in the genes known to be associated with most cases of familial HCM,” the company said in a statement. “Mutations detected in the genes are evaluated in the context of the current scientific literature, and a comprehensive report is prepared to help a patient’s physician understand and explain the results of DNA sequencing to the patient.”
HCM, affecting one out of 500 people in the US, is the leading cause of sudden cardiac death in children and young adults and accounts for 40 percent of all deaths on athletic playing fields across the US, according to the company. HCM patients are usually treated with beta blockers, calcium channel blockers, and implantable cardioverter-defibrillators or ICDs.